Table 1 Relative risks and potential impact fraction^a by sex and type of cancer

Breast (post-menopausal)

F^b

1.12 (1.09-1.15)

1.02 (1.02-1.03)

6.83 (5.25-8.39)

Colorectal

F^b

1.05 (1.02-1.08)

1.01 (1.00-1.02)

2.81 (1.16-4.45)

M^b

1.08 (1.04-1.11)

1.02 (1.01-1.02)

3.60 (1.95-5.15)

Endometrium

F^b

1.50 (1.42-1.59)

1.08 (1.07-1.10)

24.60 (23.07-26.09)

Esophagus (adenocarcinoma)

F^b

1.48 (1.29-1.71)

1.08 (1.05-1.11)

23.75 (21.54-25.95)

M^b

1.56 (1.39-1.74)

1.09 (1.07-1.12)

21.78 (19.79-23.73)

Gallbladder

F^b

1.23 (1.10-1.39)

1.04 (1.02-1.07)

12.29 (10.14-14.40)

M^b

1.23 (1.10-1.39)

1.04 (1.02-1.07)

9.84 (7.61-11.96)

Kidney

F^b

1.30 (1.25-1.36)

1.05 (1.05-1.06)

15.68 (14.12-17.20)

M^b

1.30 (1.25-1.36)

1.05 (1.05-1.06)

12.55 (10.98-14.10)

Liver

F^b

1.43 (1.19-1.70)

1.07 (1.04-1.11)

21.60 (18.97-24.21)

M^b

1.43 (1.19-1.70)

1.07 (1.04-1.11)

17.33 (14.60-20.01)

Mouth, Pharynx and Larynx

F^b

1.15 (1.06-1.24)

1.03 (1.01-1.04)

8.22 (6.36-10.04)

M^b

1.15 (1.06-1.24)

1.03 (1.01-1.04)

6.59 (4.66-8.41)

Ovary

F^c

1.06 (1.02-1.10)

1.01 (1.00-1.02)

3.17 (1.49-4.80)

Pancreas

F^b

1.10 (1.04-1.16)

1.02 (1.01-1.03)

5.57 (3.79-7.26)

M^b

1.13 (1.04-1.22)

1.02 (1.01-1.04)

5.74 (3.89-7.60)

Prostate (advanced)

M^c

1.08 (1.03-1.14)

1.02 (1.01-1.03)

3.70 (2.02-5.35)

Stomach (cardia)

F^b

1.23 (1.07-1.40)

1.04 (1.01-1.07)

12.30 (9.92-14.57)

M^b

1.23 (1.07-1.40)

1.04 (1.01-1.07)

9.84 (7.49-12.23)